SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 21st, 2020 • Aeterna Zentaris Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 19, 2020, between Aeterna Zentaris Inc., a corporation incorporated under the laws of Canada (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENT COMMON SHARE PURCHASE WARRANT AETERNA ZENTARIS iNC.Securities Agreement • February 21st, 2020 • Aeterna Zentaris Inc. • Pharmaceutical preparations
THIS PLACEMENT AGENT COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February 21, 2020 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on February 19, 2025 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Aeterna Zentaris Inc., a Canadian corporation (the “Company”), up to ______ common shares (as subject to adjustment hereunder, the “Warrant Shares”) in the capital of the Company. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Engagement Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated as of February 18, 2020.
STRICTLY CONFIDENTIAL Aeterna Zentaris Inc.Exclusive Agency Agreement • February 21st, 2020 • Aeterna Zentaris Inc. • Pharmaceutical preparations • New York
COMMON SHARE PURCHASE WARRANT AETERNA ZENTARIS iNC.Security Agreement • February 21st, 2020 • Aeterna Zentaris Inc. • Pharmaceutical preparations
THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February 21, 2020 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on August 21, 2025 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Aeterna Zentaris Inc., a Canadian corporation (the “Company”), up to ______ common shares (as subject to adjustment hereunder, the “Warrant Shares”) in the capital of the Company. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
